Skip to main content
. Author manuscript; available in PMC: 2022 Jan 1.
Published in final edited form as: J Neuropsychiatry Clin Neurosci. 2020 Oct 28;33(1):3–13. doi: 10.1176/appi.neuropsych.20060152

Table 2.

Common Alzheimer’s Disease Research Ontology (CADRO) with classes of AD therapeutic interventions (Refolo et al, 2012; Liggins et al, 2014).

Amyloid Metabolism and bioenergetics
Tau Vasculature
Apolipoprotein, lipids, lipoprotein receptors Growth factors and hormones
Neurotransmitter receptors Synaptic plasticity/neuroprotection
Inflammation Epigenetics
Oxidative stress Neurogenesis
Proteostasis/proteinopathies Other/multi-target